International safety notice

Alert 2609 (Technovigilance) - Kovalent do Brasil Ltda - TGP IFCC Interference of Sulfasalazine and Sulfapyridine in tests based on the NAD(H) and/or NADP(H) reaction principle.

Brazil / Anvisa · BRA · Jul 11, 2018

Key facts

Title Alert 2609 (Technovigilance) - Kovalent do Brasil Ltda - TGP IFCC Interference of Sulfasalazine and Sulfapyridine in tests based on the NAD(H) and/or NADP(H) reaction principle.
Regulator Brazil / Anvisa
Country BRA
Brand Trade Name: TGP IFCC Technical Name: Pyruvic Glutamic Transaminase (TGP or ALT) ANVISA registration number: 80115310051 Risk Class: II Affected model: all Affected serial numbers: all batches of the product mentioned in this notification
Manufacturer EMPRESA DETENTORA DO REGISTRO KOVALENT DO BRASIL LTDA CNPJ 04842199000156 RUA CRISTOVÃO SARDINHA 110 JARDIM BOM RETIRO SÃO GONÇALO RJ TEL 2139072534 EMAIL REGULATORIOSBIOSYSCOMBR FABRICANTE DO PRODUTO KOVALENT DO BRASIL LTDA RUA CRISTOVÃO SARDINHA 110 JARDIM BOM RETIRO BRASIL
Models 80115310051
Date Jul 11, 2018
Regulator page anvisa.gov.br

At a glance

  • No Recall
  • No Field safety notice

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About International device safety notices

Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.

Source: National medical device regulators (as listed), compiled by Orca1

Browse all International device safety notices